Clinical Trial Update: Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment Interruption [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, pharmacokinetics, and antiviral activity of the human monoclonal antibody VRC01 in HIV-infected adults undergoing a br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• VRC01 (VRC01)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2017-04-20